Pediatric Gastroenterology, Hepatology & Nutrition

  • 제21권1호
  • /
  • Pages.59-67
  • /
  • 2018
  • /
  • 2234-8646(pISSN)
  • /
  • 2234-8840(eISSN)
대한소아소화기영양학회 (The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition)
권호 표지
DOI QR코드

DOI QR Code

Different Criteria for the Definition of Insulin Resistance and Its Relation with Dyslipidemia in Overweight and Obese Children and Adolescents

  • 투고 : 2017.09.27
  • 심사 : 2017.10.26
  • 발행 : 2018.01.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: to compare cut off points corrected for age and gender (COOP) with fixed cut off points (FCOP) for fasting plasma insulin and Homeostatic model assessment-insulin resistance (HOMA-IR) for the diagnosis of IR in obese children and adolescents and their correlation with dyslipidemia. Methods: A multicenter, cross-sectional study including 383 subjects aged 7 to 18 years, evaluating fasting blood glucose, plasma insulin, and lipid profile. Subjects with high insulin levels and/or HOMA-IR were considered as having IR, based on two defining criteria: FCOP or CCOP. The frequency of metabolic abnormalities, the presence of IR, and the presence of dyslipidemia in relation to FCOP or CCOP were analyzed using Fisher and Mann-Whitney exact tests. Results: Using HOMA-IR, IR was diagnosed in 155 (40.5%) and 215 (56.1%) patients and, using fasting insulin, 150 (39.2%) and 221 (57.7%), respectively applying FCOP and CCOP. The use of CCOP resulted in lower insulin and HOMA-IR values than FCOP. Dyslipidemia was not related to FCOP or CCOP. Blood glucose remained within normal limits in all patients with IR. There was no difference in the frequency of IR identified by plasma insulin or HOMA-IR, both for FCOP and CCOP. Conclusion: The CCOP of plasma insulin or of HOMA-IR detected more cases of IR as compared to the FCOP, but were not associated with the frequency of dyslipidemia. As blood glucose has almost no fluctuation in this age group, even in the presence of IR, fasting plasma insulin detected the same cases of IR that would be detected by HOMA-IR.

키워드

참고문헌

  1. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384:766-81. https://doi.org/10.1016/S0140-6736(14)60460-8
  2. de Onis M. Preventing childhood overweight and obesity. J Pediatr (Rio J) 2015;91:105-7. https://doi.org/10.1016/j.jped.2014.10.002
  3. Nogueira-de-Almeida CA, Benedeti ACGS, Garcia J, Caixe SH. Correlation between ultrasonographic measures of the abdominal adiposity and indicators of obesity in normal and overweight/obesity children. The FASEB Journal 2016;30:1165.4.
  4. Nogueira-de-Almeida CA, Caixe SH, Benedeti ACGS, Garcia J. Echocardiography evaluation as a marker of cardiovascular risk on obese children and adolescents. The FASEB Journal 2016;30:126.1.
  5. Nogueira-de-Almeida CA, Garcia J, Caixe SH, Benedeti ACGS. Ultrasonographic assessment of the common carotid intima-media complex in normal weight children and in overweight/obese children. The FASEB Journal 2016;30:1165.3.
  6. Nogueira-de-Almeida CA, Pires LAF, dos Santos RG. Comparacao de indicadores de perfis glicemico e lipidico entre criancas e adolescentes obesos egressos de servico publico ou privado da cidade de Ribeirao Preto (SP). Medicina 2016;49:504-10.
  7. Todendi PF, Valim AR, Reuter CP, Mello ED, Gaya AR, Burgos MS. Metabolic risk in schoolchildren is associated with low levels of cardiorespiratory fitness, obesity, and parents' nutritional profile. J Pediatr (Rio J) 2016;92:388-93. https://doi.org/10.1016/j.jped.2015.10.007
  8. Sekokotla MA, Goswami N, Sewani-Rusike CR, Iputo JE, Nkeh-Chungag BN. Prevalence of metabolic syndrome in adolescents living in Mthatha, South Africa. Ther Clin Risk Manag 2017;13:131-7. https://doi.org/10.2147/TCRM.S124291
  9. Harrell JS, Jessup A, Greene N. Changing our future: obesity and the metabolic syndrome in children and adolescents. J Cardiovasc Nurs 2006;21:322-30. https://doi.org/10.1097/00005082-200607000-00014
  10. Maffeis C, Banzato C, Brambilla P, Cerutti F, Corciulo N, Cuccarolo G, et al. Insulin resistance is a risk factor for high blood pressure regardless of body size and fat distribution in obese children. Nutr Metab Cardiovasc Dis 2010;20:266-73. https://doi.org/10.1016/j.numecd.2009.04.005
  11. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 1992;327:1350-5. https://doi.org/10.1056/NEJM199211053271904
  12. Sanches Pde L, Mello MT, Fonseca FA, Elias N, Piano Ad, Carnier J, et al. Insulin resistance can impair reduction on carotid intima-media thickness in obese adolescents. Arq Bras Cardiol 2012;99:892-8. https://doi.org/10.1590/S0066-782X2012005000077
  13. Sinaiko A. Obesity, insulin resistance and the metabolic syndrome. J Pediatr (Rio J) 2007;83:3-4. https://doi.org/10.2223/JPED.1585
  14. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004;350:2362-74. https://doi.org/10.1056/NEJMoa031049
  15. Zachurzok-Buczynska A, Klimek K, Firek-Pedras M, Malecka-Tendera E. Are metabolic syndrome and its components in obese children influenced by the overweight status or the insulin resistance? Endokrynol Pol 2011;62:102-8.
  16. Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents-an IDF consensus report. Pediatr Diabetes 2007;8:299-306. https://doi.org/10.1111/j.1399-5448.2007.00271.x
  17. Pinho AP, Brunetti IL, Pepato MT, de Almeida CAN. Metabolic syndrome in overweight/obese female adolescents. Rev Paul Pediatr 2012;30:51-6. https://doi.org/10.1590/S0103-05822012000100008
  18. Levy-Marchal C, Arslanian S, Cutfield W, Sinaiko A, Druet C, Marcovecchio ML, et al. Insulin resistance in children: consensus, perspective, and future directions. J Clin Endocrinol Metab 2010;95:5189-98. https://doi.org/10.1210/jc.2010-1047
  19. Almeida CA, Pinho AP, Ricco RG, Pepato MT, Brunetti IL. Determination of glycemia and insulinemia and the homeostasis model assessment (HOMA) in schoolchildren and adolescents with normal body mass index. J Pediatr (Rio J) 2008;84:136-40. https://doi.org/10.1590/S0021-75572008000200008
  20. Garcia Cuartero B, Garcia Lacalle C, Jimenez Lobo C, Gonzalez Vergaz A, Calvo Rey C, Alcazar Villar MJ, et al. The HOMA and QUICKI indexes, and insulin and C-peptide levels in healthy children. Cut off points to identify metabolic syndrome in healthy children. An Pediatr (Barc) 2007;66:481-90. https://doi.org/10.1157/13102513
  21. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005;115:e500-3. https://doi.org/10.1542/peds.2004-1921
  22. Mieldazis SF, Azzalis LA, Junqueira VB, Souza FI, Sarni RO, Fonseca FL. Hyperinsulinism assessment in a sample of prepubescent children. J Pediatr (Rio J) 2010;86:245-9.
  23. Moran A, Jacobs DR Jr, Steinberger J, Hong CP, Prineas R, Luepker R, et al. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes 1999;48:2039-44. https://doi.org/10.2337/diabetes.48.10.2039
  24. Pastucha D, Filipcikova R, Horakova D, Radova L, Marinov Z, Malincikova J, et al. The incidence of metabolic syndrome in obese Czech children: the importance of early detection of insulin resistance using homeostatic indexes HOMA-IR and QUICKI. Physiol Res 2013;62:277-83.
  25. Ten S, Maclaren N. Insulin resistance syndrome in children. J Clin Endocrinol Metab 2004;89:2526-39. https://doi.org/10.1210/jc.2004-0276
  26. Jeffery AN, Metcalf BS, Hosking J, Streeter AJ, Voss LD, Wilkin TJ. Age before stage: insulin resistance rises before the onset of puberty: a 9-year longitudinal study (EarlyBird 26). Diabetes Care 2012;35:536-41. https://doi.org/10.2337/dc11-1281
  27. Moran A, Jacobs DR Jr, Steinberger J, Steffen LM, Pankow JS, Hong CP, et al. Changes in insulin resistance and cardiovascular risk during adolescence: establishment of differential risk in males and females. Circulation 2008;117:2361-8. https://doi.org/10.1161/CIRCULATIONAHA.107.704569
  28. Aradillas-Garcia C, Rodriguez-Moran M, Garay-Sevilla ME, Malacara JM, Rascon-Pacheco RA, Guerrero-Romero F. Distribution of the homeostasis model assessment of insulin resistance in Mexican children and adolescents. Eur J Endocrinol 2012;166:301-6. https://doi.org/10.1530/EJE-11-0844
  29. Barja S, Arteaga A, Acosta AM, Hodgson MI. Insulin resistance and other expressions of metabolic syndrome in obese Chilean children. Rev Med Chil 2003;131:259-68.
  30. Brasil AR. Criancas e adolescentes com sobrepeso ou obesidade: avaliacao da reacao inflamatoria atraves da dosagem da proteina c-reativa ultra-sensivel e prevalencia de sindrome metabolica. Belo Horizonte: UFMG, 2006.
  31. da Silva RC, Miranda WL, Chacra AR, Dib SA. Metabolic syndrome and insulin resistance in normal glucose tolerant brazilian adolescents with family history of type 2 diabetes. Diabetes Care 2005;28:716-8. https://doi.org/10.2337/diacare.28.3.716
  32. DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988;37:667-87.
  33. Kurtoglu S, Hatipoglu N, Mazicioglu M, Kendirici M, Keskin M, Kondolot M. Insulin resistance in obese children and adolescents: HOMA-IR cut-off levels in the prepubertal and pubertal periods. J Clin Res Pediatr Endocrinol 2010;2:100-6. https://doi.org/10.4274/jcrpe.v2i3.100
  34. Salazar MR, Carbajal HA, Espeche WG, Dulbecco CA, Aizpurua M, Marillet AG, et al. Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk. Diab Vasc Dis Res 2011;8:109-16. https://doi.org/10.1177/1479164111403170
  35. de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 2007;85:660-7. https://doi.org/10.2471/BLT.07.043497
  36. Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med 2002;19:527-34. https://doi.org/10.1046/j.1464-5491.2002.00745.x
  37. Back Giuliano Ide C, Caramelli B, Pellanda L, Duncan B, Mattos S, Fonseca FH. I guidelines of prevention of atherosclerosis in childhood and adolescence. Arq Bras Cardiol 2005;85 Suppl 6:4-36.
  38. Juarez-Lopez C, Klunder-Klunder M, Medina-Bravo P, Madrigal-Azcarate A, Mass-Diaz E, Flores-Huerta S. Insulin resistance and its association with the components of the metabolic syndrome among obese children and adolescents. BMC Public Health 2010;10:318. https://doi.org/10.1186/1471-2458-10-318
  39. Madeira IR, Bordallo MA, Carvalho CN, Gazolla FM, de Souza FM, de Matos HJ, et al. The role of metabolic syndrome components and adipokines in insulin resistance in prepubertal children. J Pediatr Endocrinol Metab 2011;24:289-95.
  40. Tester J, Sharma S, Jasik CB, Mietus-Snyder M, Tinajero-Deck L. Gender differences in prediabetes and insulin resistance among 1356 obese children in Northern California. Diabetes Metab Syndr 2013;7: 161-5. https://doi.org/10.1016/j.dsx.2013.06.002
  41. Angulo N, de Szarvas SB, Mathison Y, Hadad E, Gonzalez D, Hernandez A, et al. Diagnosis of insulin resistance by indirect methods in obese school children. Invest Clin 2013;54:149-60.
  42. Kim HA, Lee SY, Kwon HS, Lee SH, Jung MH, Han K, et al. Gender differences in the association of insulin resistance with metabolic risk factors among Korean adolescents: Korea National Health and Nutrition Examination Survey 2008-2010. Diabetes Res Clin Pract 2013;99:54-62. https://doi.org/10.1016/j.diabres.2012.10.011
  43. Romualdo MC, Nobrega FJ, Escrivao MA. Insulin resistance in obese children and adolescents. J Pediatr (Rio J) 2014;90:600-7. https://doi.org/10.1016/j.jped.2014.03.005
  44. Tandon N, Garg MK, Singh Y, Marwaha RK. Prevalence of metabolic syndrome among urban Indian adolescents and its relation with insulin resistance (HOMA-IR). J Pediatr Endocrinol Metab 2013;26: 1123-30.

피인용 문헌

  1. Hyperprolactinemia and insulin resistance in drug naive patients with early onset first episode psychosis vol.18, pp.None, 2018, https://doi.org/10.1186/s12888-018-1827-3
  2. Effects of Exercise in Addition to a Family-Based Lifestyle Intervention Program on Hepatic Fat in Children With Overweight vol.43, pp.2, 2018, https://doi.org/10.2337/dc19-0351
  3. Regulation of insulin resistance and glucose metabolism by interaction of PIM kinases and insulin receptor substrates vol.126, pp.2, 2020, https://doi.org/10.1080/13813455.2018.1498903
  4. COVID‐19 and obesity in childhood and adolescence: a clinical review ☆ ☆☆ vol.96, pp.5, 2018, https://doi.org/10.1016/j.jpedp.2020.07.003
  5. Critério da Associação Brasileira de Nutrologia para diagnóstico e tratamento da síndrome metabólica em crianças e adolescentes vol.13, pp.3, 2018, https://doi.org/10.1055/s-0040-1721663
  6. Metabolic syndrome definition in adolescents should incorporate insulin resistance vol.25, pp.4, 2020, https://doi.org/10.6065/apem.2040166.083